KV Pharmaceutical
     
9/6/2010 9:21:27 PM   KV.A:   KV.B:  
 
Press Releases
 
     
Financial Highlights
News
Recent Headlines
Press Releases
Conference Calls
Media Contacts
Investor Events
Investor FAQs
Investor Contacts
Annual Report & Proxy Statements
Corporate Governance
SEC Filings
Press Releases
Select Year 
    
Date 
September 02, 2010K-V Pharmaceutical Company Receives Notification From New York Stock Exchange Of Compliance With Quantitative Continued Listing Standards
August 09, 2010K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors
August 03, 2010K-V Pharmaceutical Company Engages BDO USA, LLP as Independent Registered Accountants
August 02, 2010K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance with Continued Listing Standards
July 15, 2010K-V Pharmaceutical Names Thomas Mchugh Chief Financial Officer
July 13, 2010K-V Pharmaceutical Announces Resubmission to New Drug Application for Gestiva
July 08, 2010K-V Pharmaceutical Company Receives Letter From New York Stock Exchange Regarding Delayed Filing Of Its Annual Report On Form 10-K For Fiscal Year 2010
July 07, 2010K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Director
June 18, 2010K-V Pharmaceutical Company Announces the Nomination and Appointment of New Independent Member to the Board of Directors
June 11, 2010K-V Pharmaceutical Company Announces New Board Members and Restructuring of Senior Executive Management
12
  
 
Home | Contact Us | Site Directory | Legal/Privacy | Compliance Program ©2010 KV Pharmaceutical Company. All Rights Reserved.